This paper aims to demonstrate the efficacy of the immobilisation of the chemotherapy drug doxorubicin on nanodiamond platforms as a potential cancer therapy. This effective drug is experimentally fed into a human breast adenocarcinoma cell lines. Drug loading activity and cell viability are detected by spectrometer, microscopy, and MTT assay in this study at . Experimental results show that in the basic environment (pH ¼ 8.0), the nanodiamond carboxylic group cooperated with the doxorubicin amino group to form a stable and non-covalent bond on nanodiamond surfaces served as a simple physical adsorption. In an acidic environment suitable to targeting the cancer cells, the nanodiamond carboxylic group ionised so that doxorubicin is effectively released. Doxorubicin therefore affirmatively absorbed into the cytoplasm and later into the nucleus. The significant finding of the study is that IC-50 equivalent to 0.40 mg/mL and viable nanodiamond-doxorubicin is a good candidate material for drug delivery.
ARTICLE HISTORY
We report on the experimental observation of surface plasmon resonance in Cu nanowires fabricated by shadow deposition method. When the incident light is polarized perpendicular to the wire axes, plasmon maxima appeared at about 2.3 eV in the absorption spectra. Plasmon resonance appeared at lower photon energy when the incident light is polarized parallel to the wire axes. Resonance peaks move to lower energy when the nanowire widths are increased. We have found that finite-difference time-domain (FDTD) simulation gives better results than Maxwell-Garnett model in explaining the relation between the light polarization and the energies of the observed absorption maxima. r
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.